Clinical trials are underway in Colorado for a new drug that could extend a dog's lifespan. Loyal, a San Francisco based ...

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 ...

The lion’s share of dealmaking is expected to be smaller bolt-on transactions as companies increase their exposure in fast-growing, trendy areas such as premium, snacking and health and wellness.